Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $17.41, but opened at $19.13. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $19.26, with a volume of 7,366 shares trading hands.
Analyst Ratings Changes
Several brokerages have recently issued reports on TLX. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group upped their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th.
Read Our Latest Analysis on TLX
Telix Pharmaceuticals Limited American Depositary Shares Stock Up 11.4 %
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Recommended Stories
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- What is an Earnings Surprise?
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What is the MACD Indicator and How to Use it in Your Trading
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What is a SEC Filing?
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
